SCHEMBL3722537

SCHEMBL3722537

CCCc1ccc(S(=O)(=O)N(c2ccccc2)C2CCN(C(=O)O)CC2)cc1.O=C(O)N1CC[C@H](N(c2ccccc2)S(=O)(=O)c2ccc(F)cc2)CC1CCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.39
▸ TMEM97 Q5BJF2 2/20 0.39
▸ CA12 O43570 4/20 0.36
▸ CA1 P00915 4/20 0.36
▸ CA2 P00918 4/20 0.36
▸ CA4 P22748 4/20 0.36
▸ CA5A P35218 3/20 0.36
▸ CA7 P43166 3/20 0.36
▸ CA9 Q16790 3/20 0.36
▸ CA13 Q8N1Q1 3/20 0.36
▸ CA14 Q9ULX7 3/20 0.36
▸ CHRM5 P08912 2/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ CHRM3 P20309 2/20 0.36
▸ AGTR2 P50052 5/20 0.36
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ CNR2 P34972 2/20 0.35
▸ CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3724780 0.86 TAS2R14 (0.44) CHRM5HTR2AHTR2CCNR2CNR1
SCHEMBL4783965 0.82 CHRM2 (0.44) OPRM1CA12CA1CA2CA4
SCHEMBL3723935 0.82 MCL1 (0.39) HTR2AHTR2C
SCHEMBL3725056 0.80 HSD11B1 (0.42) OPRM1CHRM5CHRM1CHRM3HTR2A
SCHEMBL4735430 0.79 CACNA1G (0.35) OPRM1TMEM97CA12CA1CA2
SCHEMBL3726385 0.77 MEN1 (0.41) CA12CA1CA2CA4CA9
SCHEMBL3727160 0.76 RORC (0.38) AGTR2HTR2AHTR2C
SCHEMBL3806319 0.75 CHRM5 (0.36) CHRM5CNR2CNR1
SCHEMBL3724470 0.74 HTR2A (0.37) OPRM1AGTR2HTR2AHTR2C
SCHEMBL3808537 0.71 CACNA1G (0.34) CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback